Primary Record
WZ4002
- In stock
- 8,189 g
- Purity
- 98.8 %
- CAS
- 1213269-23-8
Compound Identifiers & Properties
- CAS
- 1213269-23-8
- PubChem CID
- 44607530
- SMILES
- CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl)OC
- Canonical SMILES
- C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1
Names & Synonyms
- WZ4002
- 1213269-23-8
- WZ-4002
- C25H27ClN6O3
- WZ 4002
- RefChem:195086
- CHEBI:61400
- D0NJ3Q
- UNII-6BQ432Z61M
- 6BQ432Z61M
- SCHEMBL93699
- CHEMBL1229592
- cc-192
- MLS003230945
- MLS006011213
- DTXSID30153230
- MFCD16621244
- N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide
- AMY370
- GTPL9176
- orb1300949
- QCR-55
- DTXCID1075721
- SCHEMBL29354966
- SCHEMBL29733655
- CTK4B2311
- EX-A416
- ITTRLTNMFYIYPA-UHFFFAOYSA-N
- HMS3265O15
- HMS3265O16
- HMS3265P15
- HMS3265P16
- HMS3654C16
- BCP02515
- KS-00000T9M
- ABP000892
- BDBM50383274
- NSC755927
- s1173
- ZINC52509385
- AKOS025401946
- ACN-031534
- CCG-264847
- CS-0167
- EBC-224042
- NSC-755927
- RL00923
- SB19360
- SDCCGSBI-0654354.P001
- WZ-3146
- WZ-8040
- WZ4002?
- NCGC00263144-01
- NCGC00263144-02
- NCGC00263144-11
- NCGC00263144-14
- AC-27472
- AK186845
- AS-19387
- BC659932
- CID:44607530
- DA-47168
- HY-12026
- SC-95559
- SMR001913510
- SID:160644567
- AB0033756
- WZ4002, >=98% (HPLC)
- A1389
- EGFR-T790M kinase inhibitors (lung cancer)
- FT-0730384
- SW219315-1
- X7482
- EC-000.2280
- J2.786.813D
- N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide
- N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide
- A10991
- A25634
- S-7689
- C571455
- BRD-K72420232-001-12-3
- BRD-K72420232-001-13-1
- Q27089236
- N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)acrylamide
- B0084-286777
- N-[3-[[5-Chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide
- WZ4002 , WZ 4002, 213269-23-8
- EGFR-T790M kinase inhibitors (lung cancer), Gatekeeper Pharmaceuticals
- N-(3-((5-chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)acrylamide
- 0UN
- 2-PROPENAMIDE, N-(3-((5-CHLORO-2-((2-METHOXY-4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-4-PYRIMIDINYL)OXY)PHENYL)-
- 2-Propenamide, N-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-
- N-(3-((5-CHLORO-2-((2-METHOXY-4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-4-PYRIMIDINYL)OXY)PHENYL)-2-PROPENAMIDE
- N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide
- N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)anilino)pyrimidin-4-yl)oxyphenyl)prop-2-enamide
- N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazine-1-yl)phenylamino)pyrimidin-4yloxy)phenyl)acrylam
- N-[3-({5-Chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl}oxy)phenyl]prop-2-enamide
- N-[3-[2-[4-(4-Methylpiperazine-1-yl)-2-methoxyphenylamino]-5-chloropyrimidine-4-yloxy]phenyl]acrylamide